Grant Details
| Status | Active |
|---|---|
| Effective start/end date | 12/14/23 → 11/30/28 |
Serum biomarkers to predict immune related adverse events and benefit from single agent pembrolizumab therapy in early stage triple negative breast cancer
- Chung, Yunro (Roy) (CoI)
- LaBaer, Joshua (CoI)
- Song, Lusheng (CoI)
- Qiu, Ji (PI)
Project: Research project